About Actorius
Actorius is a company based in Simi Valley (United States) founded in 2013 by Aravindan Vasudevan and Murlidhara Padigaru. Actorius has raised $1.27 million across 6 funding rounds from investors including Vision Biosciences, Raj Rajeshwar Projects and Swati Khandare. Actorius offers products and services including OncoDiscover Liquid Biopsy Test. Actorius operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Simi Valley, United States
- Founders Aravindan Vasudevan, Murlidhara Padigaru
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Actorius Innovations And Research Private Limited
- Date of Incorporation 14 Aug, 2013
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$208.03 K (USD)-32.77as on Mar 31, 2023
-
Net Profit
-$261.55 K (USD)-259.44as on Mar 31, 2023
-
EBITDA
-$155.84 K (USD)-357.66as on Mar 31, 2023
-
Total Equity Funding
$1.27 M (USD)
in 6 rounds
-
Latest Funding Round
$295.93 K (USD), Seed
Nov 22, 2024
-
Investors
Vision Biosciences
& 12 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Actorius
Actorius offers a comprehensive portfolio of products and services, including OncoDiscover Liquid Biopsy Test.
Detects circulating tumor cells for cancer monitoring using minimal blood.
Funding Insights of Actorius
Actorius has successfully raised a total of $1.27M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $295.93 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Actorius
Actorius has secured backing from 13 investors, including institutional and angel investors. Prominent investors backing the company include Vision Biosciences, Raj Rajeshwar Projects and Swati Khandare.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
SK
Swati Khandare |
-
|
Locked | Locked | Locked |
Investor details for Actorius
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Actorius
Investment portfolio details for Actorius
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Actorius
Detailed financials for Actorius
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Actorius Comparisons
Peer comparison for Actorius
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Actorius
Actorius operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
Detailed competitors of Actorius
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Actorius
Complete news archive for Actorius
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Actorius
Actorius was founded in 2013 and raised its 1st funding round 7 years after it was founded.
Actorius is headquartered in Simi Valley, United States. It is registered at Simi Valley, California, United States.
Aravindan Vasudevan is the current CEO of Actorius. They have also founded this company.
Actorius is a funded company, having raised a total of $1.27M across 6 funding rounds to date.
Annual revenue of Actorius is $208.03K as on Mar 31, 2023.
Actorius was founded in 2013 in Simi Valley, United States, within the biotechnology sector focused on oncology. Genomics-based tools for cancer diagnostics are provided, including OncoDiscover Liquid Biopsy for detecting and enumerating circulating tumor cells from low blood volumes. OncoDialysis is utilized for removing these cells, and drug formulations for cancer treatment are developed. Operations center on advancing precision medicine through these technologies.
Actorius's top competitors include Guardant Health, Foundation Medicine and Natera.
Actorius offers OncoDiscover Liquid Biopsy Test.
Actorius has 13 investors. Key investors include Vision Biosciences, Raj Rajeshwar Projects, Swati Khandare, Manoj Mathew, and unknown.